Comparison of Clinicopathologic Characteristics and Outcomes after Resection in Patients with Hepatocellular Carcinoma Treated in the United States, France, and Japan

Annals of Surgery

Volumn 238, Issue 5, 2003, Pages 711-719

  Esnaola, Nestor F ^a   Mirza, Nadeem ^a   Lauwers, Gregory Y ^b   Ikai, Iwao ^c   Regimbeau, Jean Marc ^d   Belghiti, Jacques ^d   Yamaoka, Yoshio ^c   Curley, Steven A ^a   Ellis, Lee M ^a   Nagorney, David M ^e   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d BEAUJON HOSPITAL   (France)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HISTOPATHOLOGY; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME; TUMOR VOLUME; UNITED STATES; COMPARATIVE STUDY; HEPATITIS B; LIVER TUMOR; MORTALITY; PATHOLOGY; SURVIVAL; VIROLOGY;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FRANCE; HEPATITIS B; HEPATITIS C; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 17144435259     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000094436.34556.ac     Document Type: Article

References (42)

1. Bosch FX. Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E, eds. Liver Cancer. New York: Churchill Livingstone; 1997:13-28.
2. Di Bisceglie AM. Malignant tumors of the liver. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver, 8th ed. Philadelphia: Lippincott-Raven; 1999:1281-1304.
3. El-Serag H. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001;5:87-107.
4. Falk H. Liver. In: Schottenfeld D, Fraumeni J, eds. Cancer Epidemiology and Prevention. Philadelphia: Saunders; 1982:668-682.
5. Ezaki T, Stansby G, Hobbs K. Regional differences in hepatocellular carcinoma and its surgical treatment. HPB Surg. 1991;4:121-128.
6. Simonetti R, Camma C, Fiorello F, et al. Hepatocellular carcinoma: a worldwide problem and the major risk factors. Dig Dis Sci. 1991;36: 962-972.
7. El-Serag H, Mason A. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-750.
8. Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211:277-287.
9. Azii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology. 2000;32:1224-1229.
10. Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer. Tokyo: Kanehara; 1997.
11. Couinaud C. Plaidoyer pour une segmentation hepatique exacte et une technique anatomique de resection reglee du foie. Presse Med. 1966;74: 2849-2852.
12. Strasberg SM. The Brisbane 2000 terminology of hepatic anatomy and resections. HPB. 2000;2:333-339.
13. Hermanek P, Henson DE, Hutter RVP, et al., eds. TNM Supplement. Berlin: Springer-Verlag; 1993.
14. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462-503.
15. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
16. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
17. Peto R, Peto J. Asymptomatically efficient rant invariant test procedure. J R Stat Soc. 1972;135:185-206.
18. Liver (including intrahepatic bile ducts). In: Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Sterging Manual, 6th ed. Philadelphia: JB Lippincott; 2002:131-144.
19. Kosuge T, Makuuchi M, Takayama T, et al. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology. 1993;40:328-332.
20. Izumi R, Shimizu K, Ii Tohru II, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 1994;106:720-727.
21. Vauthey JN, Klimstra D, Franceschi D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg. 1995;169:28-34.
22. Fong Y, Sun RL, Jamagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg. 1998;229:790-800.
23. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Center of the Liver Italian Program (CLIP) investigators. Hepatology. 2000;28:751-755.
24. Llovet JM, Bru C, Bruix J. Proganosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329-338.
25. Cancer of the Italian Liver Program Investigators Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000;31:840-845.
26. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer. 1985;56:918-928.
27. Vauthey JN, Lauwers GY, Esnaola NF, et al. A simplified staging system for hepatocellular carcinoma. J Clin Oncol. 2002;20:1527-1536.
28. Smalley SR, Moertel CG, Hilton JF, et al. Hepatoma in the noncirrhotic liver. Cancer. 1988;62:1414-1424.
29. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg. 1995;19:35-41.
30. Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery. 2000;127:603-608.
31. Esnaola NF, Lauwers GY, Mirza NQ, et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg. 2002;6:224-232.
32. Vauthey JN, Sobin LH. On the uniform use of the AJCC/UICC staging system for hepatocellular carcinoma. Surgery. 2000;128:870.
33. Nelson RC, Chezmar JL, Sugarbaker PH, et al. Preoperative localization of focal liver lesions to specific liver segments: utility of CT during portography. Radiology. 1990;176:89-94
34. Bach AM, Hann LE, Brown KT, et al. Portal vein evaluation with United States: comparison to angiography combined with CT arterial portography. Radiology. 1996;201:149-154.
35. Hann LE, Schwartz LH, Panicek DM, et al. Tumor involvement in hepatic veins: comparison of MR imaging and United States for preoperative assessment. Radiology. 1998;206:651-656.
36. Takenaka K, Yamamoto K, Taketomi A, et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology. 1995;22:20-24.
37. Yamanaka N, Tanaka T, Tanaka W, et al. Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer. 1997;79:1509-1515.
38. Chen MF, Jeng LB, Lee WC, et al. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with B- or C-related hepatocellular carcinoma. Surgery. 1998;123:554-559.
39. Kubo S, Nishiguchi S, Hironashi K, et al. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer. 1999;86:793-798.
40. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105:488-494.
41. Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996;83:1219-1222.
42. Bilimoria MM, Lauwers GY, Doherty DA, et al. Underlying liver disease but not tumor factors predict long-term survival after hepatic resection of hepatocellular carcinoma. Arch Surg. 2001;136:528-535.